Log In
BCIQ
Print this Print this
 

CD201

  Manage Alerts
Collapse Summary General Information
Company Cidara Therapeutics Inc.
DescriptionBispecific antimicrobial immunotherapy for MDR infections
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationGram-negative bacterial infection
Indication DetailsTreat multi-drug resistant Gram-negative bacterial infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today